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Background: Today, health care is patient-centred with patients more involved in medical decision making and
taking an active role in managing their disease. It is important that patients are appropriately informed about their
condition and that their health care needs are met. We examine the information utilisation, sources and needs of
people with Ankylosing Spondylitis (AS).
Methods: Participants in an existing AS cohort study were asked to complete a postal or online questionnaire
containing closed and open-ended questions, regarding their information access and needs. Participants were
stratified by age and descriptive statistics were performed using STATA 11, while thematic analysis was performed
on open-ended question narratives. Qualitative data was handled in Microsoft Access and explored for emerging
themes and patterns of experiences.
Results: Despite 73% of respondents having internet access, only 49% used the internet to access information
regarding AS. Even then, this was only infrequently. Only 50% of respondents reported accessing written
information about AS, which was obtained mainly in specialist clinics. Women were more likely than men to access
information (63% (women) 46% (men)) regardless of the source, while younger patients were more likely to use
online sources. The main source of non-written information was the rheumatologist. Overall, the respondents felt
there was sufficient information available, but there was a perception that the tone was often too negative. The
majority (95%) of people would like to receive a regular newsletter about AS, containing positive practical and local
information. Suggestions were also made for more information about AS to be made available to non-specialist
medical professionals and the general public.
Conclusions: There appears to be sufficient information available for people with AS in the UK and this is mostly
accessed by younger AS patients. Many patients, particularly men, choose not to access AS information and
concerns were raised about its negative tone. Patients still rely on written and verbal information from their
specialists. Future initiatives should focus on the delivery of more positive information, targeting younger
participants in particular and increasing the awareness in the general population and wider non-specialist medical
community.
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Ankylosing Spondylitis (AS) is a chronic inflammatory
arthritis that affects the axial skeleton. The disease typic-
ally occurs during the third decade of life [1-3] and affects
2.5 times more men than women [4]. The prevalence of
ankylosing sponylitis is unknown although estimates from
data from the UK and Hungary suggest a range between
0.05% to 0.23% [5].
Providing information to patients with chronic musculo-
skeletal diseases is recognised as good practice. There is,
however, limited published literature exploring the infor-
mation needs of people with arthritis [6-8], with the focus
mainly on those with rheumatoid arthritis (RA) and osteo-
arthritis (OA). A study from Scandinavia found that
patients with AS received significantly more information
about diagnosis and medication than patients with RA [7].
There are also increasing numbers of websites providing
information about AS, such as Patient.co.uk, National
Ankylosing Spondylitis Society (NASS), Medicinenet.
com, Arthritis Research UK and AS Assist [9-13].
As part of the MRC-funded Patient Research Cohort
Initiative [14], we established the Population-based An-
kylosing Spondylitis (PAS) cohort [15], which captures
longitudinal data on patients with AS living in Wales,
United Kingdom (UK). We wanted to provide the parti-
cipants of the PAS study with information about AS and
set out to examine the information needs and prefer-
ences of people with AS by exploring participant access,
usage and opinion of available sources of AS informa-
tion, an area which to date has been largely neglected.
Methods
Participants
People with AS who were resident in Wales, UK were
recruited to the PAS cohort through their general practi-
tioner (GP), rheumatologist, membership of the National
Ankylosing Spondylitis Society (NASS), or through
physiotherapy [15]. Information packs were sent directly
to AS patients attending a rheumatologist inviting them
to join the cohort; via participating GP surgeries whereby
information packs were distributed from GP to AS
patients; through regional NASS coordinators who sent
the information packs to their members, and finally, from
physiotherapists to their patients diagnosed with AS.
This study draws on the data collected from members of
the PAS cohort who completed the information needs
questionnaire (please see additional 1 files for a copy of
the questionnaire).
Procedures
Questionnaire
All participants recruited as part of the PAS cohort were
asked to complete (n = 418) a postal or online question-
naire about information needs, developed by a team ofresearchers and a rheumatologist at Swansea University.
Participants were reminded by post or via email to
complete the questionnaire, up to a total of two times in
an attempt to improve participation rates.
The questionnaire consisted of open and close-ended
questions to investigate the access and usage of informa-
tion sources (e.g. electronic, paper based or health pro-
fessionals), barriers and drivers for information use,
frequency of information utilisation, appraisal of existing
information and identification of information gaps. In
addition, the Bath Ankylosing Spondylitis Disease Activity
Index (BASDAI) [16], the Bath Ankylosing Spondylitis
Functional Index (BASFI) [17] and a current health status
measure, Euro-Qol-5 Dimensions (EQ-5D) [18] were
included in the questionnaire. The BASADI consists of
10 cm visual analogue scales (VAS) used to answer 6
questions pertaining to the 5 major symptoms of AS.
Scores range from 0–100 with scores of 40 or above sug-
gesting suboptimal control of the disease. Similar to the
BASDAI, the 10-item BASFI uses a 10 cm VAS to assess
the AS patients’ functional ability. A score is calculated
(0–100) to give an indication of patient disability. The
EQ-5D comprises five dimensions: mobility, self-care,
usual activities, pain/discomfort and anxiety/depression,
and the respondent chooses an accompanying statement
which indicates whether there are no problems, some
problems or extreme problems in each of the dimensions.
In addition, a 0–100 point VAS is used in the EQ-5D
with the endpoints ‘Best imaginable health state’ (point
100 of scale) and ‘Worst imaginable health state’ (point 0
of scale).Routine data
Working in collaboration with the Health Information
Research Unit (HIRU) at Swansea University, we explored
routinely collected GP records currently held on 1,592,484
patients in Wales, to examine whether response rate bias
was an issue during this study. The HIRU’s Secure Anon-
ymised Information Linkage (SAIL) databank [19], which
currently holds over a billion records from various
sources such as GP records, in-patient and out-patient
data, overcomes confidentiality and disclosure issues by
using a robust split-file approach [20].
Here, we utilised the GP records of the SAIL databank
to explore the age and the gender of 1,920 people held
in the database who were identified as having a diagnosis
of AS and living in Wales, to compare with the demo-
graphic profile of the participants in our study.Analysis of data
Participants were stratified by age (20–39 years, 40–
59 years and over 60 years old). Descriptive statistics
were calculated for participant characteristics using
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culated as means and standard deviations.
The responses to open ended questionnaire items were
handled in Microsoft Access and explored for patterned
responses and emerging themes using thematic analysis.
Following a period of extensive data familiarisation
which involved repeated and active reading, all open
ended question responses were included for analysis and
used to combine and catalogue a comprehensive picture
of the collective experiences and opinions regarding the
information needs of AS patients. A data-driven and se-
mantic level approach to identifying was taken. Decided
themes were coded accordingly by one researcher (RC)
and refined in a recursive process as the data was ana-
lysed. The themes and coding practices were checked by
another researcher (SB). A comprehensive account of
thematic analysis is available elsewhere [21].
Ethical approval and consent
This study obtained ethical approval from the London
Multi-centre Research Ethics Committee and the written
consent of participants was obtained according to the
declaration of Helsinki.
Results
Demographics
Questionnaires were completed by 211 out of 418 parti-
cipants (50% response rate).
The sample was 81% male and the mean age of the
respondents was 57 [see Table 1], with 10% (22/211)
aged 20–39 years, 36% (77/211) aged 40–59 years and
52% (112/211) aged 60+. The sample was not represen-
tative of the whole PAS cohort as younger individuals
participated less.
In comparisons to Wales-wide data we found that
Welsh resident patients diagnosed with AS, identified
from GP records held in the SAIL databank (n = 1920),
were 75% male, the mean age was 60, with 13% (241/
1920) aged 20–39 years, 36% (683/1920) aged 40–59 years
and 52% (996/1920) aged 60 and over. Demographic data
is provided in Table 1.Table 1 Respondent demographics
Mean age (n = 211) 57 (S.D: 13)
Male (n = 211) 81% (171/211)
Mean BASDAI (n = 211) 43 (S.D: 22)
Mean BASFI (n = 211) 51 (S.D: 28)
Age at diagnosis (n = 206) 33 (S.D: 12)
Age first symptoms (n = 203) 25 (S.D:10)
Disease duration from diagnosis (years) (n = 206) 23 (S.D: 14)
Disease duration from first symptom (years) (n = 203) 32 (S.D: 14)
Have children (n = 211) 73% (155/211)Information sources
Internet
The majority of respondents had access to the internet
(73% (155/211); 95%CI: 67% to 79%)) with highest rates
among younger participants (91% (20/22); 95%CI: 72%
to 97%) aged 20–39.
The internet was used more for social networking by
younger people than older people (64% (14/22); 95%CI:
43% to 80%) in those aged 20–39 compared to 7% (8/112);
95%CI: 3.6% to 13.5% in those aged 60 and over).
Less than half (49% (103/211); 95%CI: 42% to 56%)
used the internet for information about AS, and of these,
the frequency of online AS information searching was
most commonly reported as “every 6 months or less”
(58% (60/103); 95%CI: 49% to 67%).
The majority of younger participants (age 20–39)
reported using the internet to find out about AS (77%
(17/22); 95%CI: 56% to 90%) compared to 36% (40/112);
95%CI: 28% to 45%) of those aged 60 +.
The mean disease severity (BASDAI) and mean health
status (EQ5D) for those who accessed online AS infor-
mation (mean disease severity 43 (sd: 22) and mean
health status 55 (sd: 22)) was similar to that of individuals
who did not access online AS information (mean disease
severity 43 (sd: 23) and mean health status 57 (sd: 23)).
The main reasons given for not using the internet for
AS information included not needing or wanting further
information and not trusting information on the internet
[Table 2].
The majority of respondents (79% (90/114); 95% CI:
71% to 85%)) rated the currently available online AS in-
formation as ‘helpful’. The information that people would
like to see provided on the internet included summaries
of the latest research and medications (61% (95/155);
95%CI: 53% to 69%)), the opportunity to ask a doctor
questions (43% (66/155); 95%CI: 35% to 50%)) and AS
networking (25% (39/155); 95%CI: 19% to 33%)).
From open-ended question responses, other information
that people would like to see on the internet included
help-lines, practical information about dealing with AS
and a facility whereby patients could contact the rheuma-
tology clinic they attend, although the numbers reporting
these were small.
Written information
Only half of all the respondents reported obtaining written
information on AS (50% (105/211), 95%CI: 43% to 56%).
This was obtained mostly from hospital clinics (33%
(70/211), 95%CI: 27% to 40%) national charities (18%
(39/211); 14% to 24%)) and GP surgeries (12% (25/211);
95%CI: 82% to 17%) but rarely from libraries (3% (7/211);
95%CI: 2% to 7%), and books or other places (2% (5/211);
1% to 5%). For those who had no access to the internet,
61% (34/56; 95%CI: 48% to 72%) picked up written
Table 2 Quotes from comments made by respondents in the Information Needs Questionnaire
Reasons not accessing AS information
online:
Quote
Don’t need further information “I do not need to know any further information as I am already informed.” (Male, aged 70)
“I think that there is enough information via leaflets, AS sites and health sites.” (Female, aged 43)
“. . .I do not need to keep reading things. I know I have a stiff back but do not need to keep reading
about things.” (Male, aged 51)
Don’t want further information “Having AS is bad enough, I don’t want to read about it!” (Male, aged 62)
“Don’t always feel like [using internet for AS information].” (Female, aged 50)
“all doom and gloom”. (Male, aged 32)
Don’t trust the information “It is difficult to know which sites to trust” (Male, aged 37)“
“Possible safety implications [discourage me from accessing AS information online]”. (Female, aged 65)
Dislike Internet “I don’t use the internet or a computer as I think it is the biggest backward set mankind has ever
made.” (Male, aged 62)
“A load of rubbish on it.” (Male, aged 64)
Time constraints “I have an 18 month old that keep me busy – no time.” (Female, aged 38)
“Can be time consuming – too much info.” (Male, aged 51)
Don’t think to look for information “Don’t always think about looking as I have had AS for so long.” (Female, aged 50)
“[Looking up AS online] Does not occur to me generally.” (Female, aged 71)
Prefer information from professional “I prefer to talk to a professional, face to face.” (Male, aged 55)
“I feel supported by my rheumatologist and have never felt the need to turn to anyone else. . .”
(Female, aged 65)
Confusing information, do not understand “Difficult to understand [information].” (Male, aged 63)
“Not understanding properly what [information] I need.” (Female, aged 40)
Suggestions for improving information
and support:
Improved access to professionals/services “More available access to AS professionals - I see physio once a year if I am lucky.” (Female, aged 44)
“A more efficient means of accessing medical help. I have waited for up to 18 months to see a
consultant.” (Male, aged 66)
“The main issue is access to specialists. GPs often seem to know little about conditions such as AS and
my consultants AS clinic (which is very good) only takes place every 3–6 months. There is a need to
be able to discuss issues arising from flare-ups while they are occurring - not weeks or months later,”
(Male, aged 37).
Happy with current level of AS Information “I am happy now with the information I receive. However when I was really bad it was very hard to
get to the people I needed to see.” (Female, 49)
“Satisfied with the information and support that I have received.” (Female, 62)
“As of the moment I am more than happy with the excellent level of support received from the
rheumatology department at my local hospital - A veritable breath of fresh air, thank you.” (Male, 55)
Improved GP knowledge and support “GP knows little about AS. GPs should be better informed and show interest at least.” (Male, aged 60)
“Doctors that listen to you when you tell them that you get back pain so painful it gives me
breathing problems.” (Male, aged 29)
“I don’t always find GPs very knowledgeable about AS and sometimes they are quite dismissive of the
condition.” (Female, aged 29)
AS groups or advice from others “Swapping stories and self help, get AS sufferers to socialise with each other.” (Male, aged 34)
“A helpline for people to contact for help e.g. for backup about the disease in relation to sickness
claims and advice on drugs.” (Male, aged 47)
Information on cause and treatment “Generally greater information on the cause of AS and the known treatments available. Plus what new
treatments are coming onto the market or will be available in the near future.” (Male, aged 46)
More written information “I would buy from book shops but I have never seen any books on AS.” (Male, aged 50)
“I think the leaflets on AS should be displayed in GP surgeries or Hospitals. There are ones on Arthritis
but nothing for AS.” (Male, aged 77)
Cooksey et al. BMC Musculoskeletal Disorders 2012, 13:243 Page 4 of 8
http://www.biomedcentral.com/1471-2474/13/243
Table 2 Quotes from comments made by respondents in the Information Needs Questionnaire (Continued)
More electronic information “Better (more comprehensive) internet facility.” (Male, aged 41)
“Regular emails to provide recent findings and other peoples experiences,” (Male, aged 36).
Updates to current news/research “Updates regarding new treatments or therapies.” (Male, aged 66)
“Regular feedback from health professionals as to research and different treatments available.”
(Male, aged 46)
Better public awareness “Not many people understand AS so if information was presented in simple language more people
could have a better understanding of what people with AS suffer.” (Female, aged 61)
“I think it would be a good idea to make people aware of AS through the media, perhaps then
people would not shrug off an aching back for weeks on end before getting checked out. . .”
(Male, aged 61)
“More understanding from everyone, just even if people were more aware as with other inflammatory
diseases.” (Male, aged 29)
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54%) with internet access.
The vast majority of patients (95%, (157/166)) reported
that they would like to receive a regular or occasional
newsletter about AS. The majority of participants stated
that they would like to see summaries of the latest AS
research (65% (138/211); 95%CI: 59% to 71%), stories
and experiences from other AS patients (43% (90/211;
95%CI: 36% to 49%), an opportunity to ask a doctor
about questions (35% (74/211; 95%CI: 29% to 42%) and
information about local events (27% (56/211); 95%CI:
21% to 33%) in newsletters about AS.
From open-ended question responses provided, parti-
cipants appear to favour practical information, medica-
tion information and self-help guidance over purely
factual information about the disease course itself and
would like to see such information contained in AS
newsletters. Participants felt that information on the dis-
ease itself was readily available and reading it would not
change their outcome and as such, was of limited help
to them. Some even replied that they would prefer to
not know about this information; “It never has a positive
angle, it’s always ‘this will or could happen’, [it’s all]
doom and gloom” [Table 2].Non-written information sources
The rheumatologist (56% (117/209); 95%CI: 49% to
63%), the GP (37% (77/209); 95%CI: 31% to 44%) and
the nursing and physiotherapy team (35% (68/209); 95%
CI: 27% to 39%) were the main sources of non-written
or non-electronic information. Friends and family were
used the least as a source of information (20% (41/209;
95%CI: 15% to 26%).Information needs by age and gender
Rates of AS information gathering were higher in females
than in males, regardless of the source of information,
66% (27/41) of females accessed online AS informationcompared with 46% (79/170) of males (difference: 19%;
95%CI: 2.3% to 34%) and similarly, 63% (26/41) of females
obtained written AS information compared with 46%
(79/170) of males (difference 17%; 95%CI: 0% to 32%).
Younger participants aged 20–39 years appear to have
some differing information needs from older partici-
pants; younger participants had higher rates for acces-
sing AS information online (77%, 17/22) and lower rates
for obtaining written information (41%, 9/22) (difference
36%; 95%CI: 7% to 58%).
Thematic analyses revealed that older participants
more frequently reported that they were happy with the
level of AS information available and that they did not
want any more information. All age groups expressed
the view that GP knowledge and support, access to spe-
cialist healthcare professionals and services, AS groups
or advice from others and updates of current news and
research could be improved [Table 2].Improving information delivery
When asked in an open question about how AS infor-
mation and support could be improved, the most com-
monly reported recommendation was for improved
access to AS specialists and services. Many participants
stated that they were happy with the current level of AS
information available to them. However, participants
would like to see improved GP knowledge and support
and improved public awareness about AS [Table 2].Discussion
People with AS in our cohort appear to be largely con-
tent with the level of information currently available to
them and feel generally well informed about their condi-
tion which replicates previous findings in people with
AS [7,21]. This is not apparent for individuals with RA
where a lack of knowledge has been reported [7,22-24].
Furthermore, we found that many participants did not
want any further information about AS. This could
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compared to RA. Indeed, here we found that in all age
groups, women were more likely to seek information
about AS than men.
The majority of our respondents were older (mean age
57 years), and would therefore have had AS for several
decades. AS is generally a slow, progressive disorder, so
many patients with long-standing disease would have
learned to cope and manage their condition. In contrast,
the younger participants did require further information
and the majority of this group used the internet for this
purpose. Therefore, the information needs for newly
diagnosed AS patients appear to differ from those with
established disease and information provision should be
targeted to younger patients.
Several respondents perceived available information
about AS as “doom and gloom” and many respondents
expressed that they would rather not know about all of
the complications and problems associated with the con-
dition. As such, it appears that the tone of the informa-
tion is too negative and may explain why participants
generally reported they were ‘satisfied’ with the amount
of AS information available, when in fact they did not
want to read any more depressing information. In RA,
patients have described the need for additional informa-
tion regarding therapies and treatments, scientific devel-
opments and social support, improving symptoms and
quality of life while information about the disease itself
was mentioned last [24]. This suggests that information
on new therapies and proactive advice is more useful to
patients with chronic inflammatory arthritis, rather than
information relating to the mechanisms, complications
and prognosis of the disease itself, which does little to
help improve quality of life or health outcomes. New in-
formation should aim to be more positive to avoid mak-
ing people with AS feel despondent when reading about
their condition, particularly now that there are effective
therapies available for AS.
The utilisation rates of written AS information and
online information were quite low (50% and 49%, re-
spectively) and accessed infrequently (on average every
6 months or less), with older participants most frequently
accessing written sources and the younger accessing
predominantly online information. Previous studies have
shown that new rheumatology patients look up their
symptoms prior to their first rheumatology appoint-
ment and that 62.5% of patients sought this information
online [25].
Despite participants reporting low utilisation rates of
both written and electronic information, and fre-
quently stating they neither wanted nor needed fur-
ther information, the vast majority would still like to
receive a newsletter. This suggests that AS patients
are interested in regular updates of new and relevantAS information in a newsletter format. This could be
achieved at a relatively low cost and involve people with
AS at the design stage to ensure that the content and
tone is appropriate.
Participants wanted easier access to specialists for in-
formation, suggesting a need for more personalised infor-
mation rather than generic information about AS, which
is a heterogeneous condition with a variable course.
However, we realise that it is not necessarily practical for
AS patients to enjoy easier access to specialists, due to
availability and costs associated with specialised, one-to-
one healthcare on a more regular basis. Further investi-
gations may be useful to explore the costs related to
more regular contact with a specialist compared with
costs associated with increased visits to the GP and util-
isation of other and perhaps less appropriate health care
provisions that may occur as a result.
Rather than wanting more information for themselves,
many respondents felt there was a need for improved in-
formation for non-specialist healthcare professionals and
the general public. Again, this may reflect the fact that
the majority of our respondents were older with long-
standing disease, and therefore had an understanding of
their own disease, but still felt that others did not under-
stand it. This could be a particular issue for AS where
the main burden of disease is in the spine with relatively
little to see in terms of peripheral joint swelling or de-
struction compared to conditions like RA or OA. AS is
associated with fatigue and unpredictable flares of disease
activity which may be difficult for others to appreciate
and understand. With this in mind, future initiatives
could be developed to help raise the awareness of AS for
GPs and primary care teams in order to extend the avail-
able support for AS patients which may also help address
the delay in AS diagnosis. The participation of non-
specialist medical professionals in local groups and train-
ing sessions may serve to help address this.
As is the case in this study, the need for GPs to be
better informed has also been highlighted in a study
with multiple sclerosis patients [26] and similarly in a
focus group study with elderly participants, where lack
of time with GPs and questions left unanswered by
health care providers was a barrier to participants under-
standing health information [27]. Information from
GPs and primary care teams will become increasingly im-
portant as the long-term management of chronic condi-
tions is increasingly being delivered in the community
and primary care settings, with limited access to special-
ist services.
In addition to improved GP awareness, AS patients also
feel that greater public awareness of AS is required and so
projects to help raise the profile of AS are likely to benefit
the AS community. The College of Medicine at Swansea
University have organised successful AS Awareness days
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feel helps raise awareness of the condition.Limitations of the study
The response rate for this questionnaire was relatively
low (50%), compared to the response rates of the same
cohort of AS patients for other questionnaires about dis-
ease flares, fatigue or work which have all been ≥70%.
This low rate may suggest ambivalence regarding the
issue of AS information which is reflected in the open
question responses. Indeed, similar low responses have
been reported in other studies investigating the informa-
tion needs of patients with arthritis (58% response rate)
[7,22] and 63% [23].
The majority of younger patients in the PAS cohort
did not reply to the questionnaire. Therefore, the find-
ings of the study can only reflect the responses of partici-
pants who are motivated to complete this questionnaire
and this group may have different views from those who
did not participate. The majority of respondents were
older, and by definition would have longstanding disease
and their information needs may differ significantly from
patients with a recent diagnosis of AS. For example,
younger men may not be receptive to information in the
early stages and this group of young men may be difficult
to reach effectively using traditional means. However,
this study was stratified by age in order to compare the
information needs between the different age groups.
This study has revealed a general lack of need for more
patient information about AS and a discontentment with
the negative content of current available information,
which may explain the apparent apathy in completing a
questionnaire about AS information.Conclusions
Patients with AS are generally satisfied with the amount
of information available to them, but not the negative
tone in which it is delivered. Information provided ought
to be more practical and positive, particularly now that
effective therapies are available for AS. Information util-
isation and needs differ across gender and age groups,
which should be considered in order to reach all target
populations. The internet is a useful tool for delivering
AS information to those who seek it; predominantly the
youngest generation and websites and forums allow the
sharing of experiences and offer practical and encour-
aging advice.
The importance of specialist rheumatology services as
sources of information was identified by participants, as
well as the need for improved non-specialist healthcare
professional and public awareness of AS. Healthcare
professionals with expertise in AS, in conjunction withAS patients should be involved in developing strategies
to address this information gap.
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